Free Trial
→ Shots officially fired… (From Brownstone Research) (Ad)tc pixel

NorthWest Health Prop Real Est Inv Trust (TSE:NWH.UN) Share Price Passes Below 200-Day Moving Average - Time to Sell?

Written by MarketBeat
October 17, 2025
NorthWest Health Prop Real Est Inv Trust logo with Real Estate background

Key Points

  • The share price of NorthWest Health Prop Real Est Inv Trust (TSE:NWH.UN) fell below its 200-day moving average of C$4.92 during trading on Thursday, indicating potential volatility.
  • The company has a high debt-to-equity ratio of 129.42, suggesting significant leverage and potential financial risk.
  • NorthWest Health is focused on a well-diversified portfolio of healthcare real estate across regions including Australasia, Brazil, Germany, and Canada, with Australasia being a primary revenue source.
  • Five stocks to consider instead of NorthWest Health Prop Real Est Inv Trust.

NorthWest Health Prop Real Est Inv Trust (TSE:NWH.UN - Get Free Report)'s stock price passed below its two hundred day moving average during trading on Thursday . The stock has a two hundred day moving average of C$4.92 and traded as low as C$4.92. NorthWest Health Prop Real Est Inv Trust shares last traded at C$4.93, with a volume of 430,902 shares trading hands.

NorthWest Health Prop Real Est Inv Trust Price Performance

The company has a current ratio of 0.25, a quick ratio of 0.06 and a debt-to-equity ratio of 129.42. The company has a market capitalization of C$1.23 billion, a P/E ratio of -11.76, a P/E/G ratio of 0.74 and a beta of 1.44. The company has a 50 day moving average price of C$5.01 and a 200 day moving average price of C$4.92.

About NorthWest Health Prop Real Est Inv Trust

(Get Free Report)

Northwest Healthcare Properties Real Estate Investment Trust provides investors with access to a portfolio of high-quality healthcare real estate. The company provides investors exposure to a well-diversified portfolio of healthcare real estate located in the greater areas of cities such as Australasia, Brazil, Germany, and Canada of which Australasia derives a majority of revenue to the company.

See Also

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in NorthWest Health Prop Real Est Inv Trust Right Now?

Before you consider NorthWest Health Prop Real Est Inv Trust, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and NorthWest Health Prop Real Est Inv Trust wasn't on the list.

While NorthWest Health Prop Real Est Inv Trust currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

A Guide To High-Short-Interest Stocks Cover
A Guide To High-Short-Interest Stocks

MarketBeat's analysts have just released their top five short plays for November 2025. Learn which stocks have the most short interest and how to trade them. Enter your email address to see which companies made the list.

Get This Free Report
Like this article? Share it with a colleague.